Triptolide: A Potential Drug For Polycystic Kidney Disease

A treatment for polycystic kidney disease (PKD), a leading cause of fatal kidney failure worldwide, has been identified by a research team led by Yale biochemist Craig Crews, according to a report in the Proceedings of the National Academy of Sciences. [click link for full article]

» original article | source | add new comment | 52 reads

Popular content

Today's:

A prospective, non-randomized phase-II trial of Trastuzumab and Capecitabine in patients with HER2 expressing advanced pancreati
State high court backs consumers in health care billing - Sacramento Bee
Survey Reveals Lack Of Local Direction Is A Key Reason For GPs Not Implementing Nice Guidance On Ezetimibe

Last viewed:

Who's online

There are currently 0 users and 104 guests online.

Browse archives